Paloma Partners’s AVEO Pharmaceuticals AVEO Stock Holding History
Bought
Maintained
Sold
Other funds holding AVEO
6CM
Paloma Partners's AVEO Position: Q3 2019 in Review
Paloma Partners sold out of AVEO Pharmaceuticals (AVEO) in Q3 2019, closing a stake of 47,713 shares — an estimated $321K sold.
Paloma Partners first reported a position in AVEO in Q2 2014 and held it in 4 quarters. The position peaked at $409K in Q2 2014. 59 funds tracked by Wall St. Rank hold AVEO as of Q3 2019.
- Paloma Partners reported no remaining AVEO Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
- Paloma Partners sold 47,713 AVEO Pharmaceuticals shares in Q3 2019, an estimated $321K.
- Paloma Partners first reported a position in AVEO Pharmaceuticals in Q2 2014 and held it in 4 quarters.
- Paloma Partners's AVEO Pharmaceuticals position peaked at $409K in Q2 2014.
- 59 funds tracked by Wall St. Rank held AVEO Pharmaceuticals as of Q3 2019.
Based on Paloma Partners's 13F filing for Q3 2019, filed 14 Nov 2019.